Skip to content
New: free dose calculator with 14 peptide presets. No signup.
Peptides Academy
Pinealon
Cognitive / Nootropic

Pinealon

Research-Grade

Pinealon is a synthetic tripeptide, Glu-Asp-Arg (EDR), from the family of short 'bioregulator' peptides developed by Vladimir Khavinson's group at the St. Petersburg Institute of Bioregulation and Gerontology. That group proposes that ultra-short peptides enter cells, reach the nucleus and bind DNA or histones to regulate gene expression. Nearly all published research on Pinealon comes from this group and its collaborators, much of it in Russian-language journals. In cell studies, Pinealon limited the build-up of reactive oxygen species and reduced cell death in rat cerebellar neurons, neutrophils and PC12 cells, and fluorescence-labelled EDR entered the cytoplasm and nucleus of HeLa cells. In rats, giving Pinealon to pregnant animals with experimental hyperhomocysteinemia improved their offspring's learning and spatial orientation, and it altered brain neurochemistry in aged rats exposed to hypoxia and cold. In a mouse model of Alzheimer's disease, EDR prevented loss of dendritic spines. Human evidence is sparse: a 32-person Russian study in patients with organic brain syndrome reported changes in biological-age markers with Pinealon and Vesugen, alongside pro-oxidant activity and reduced CD34+ cells, and a study of truck drivers reported improved psycho-emotional measures with combined peptide courses. Neither was a large randomized trial, and none has been replicated outside Russia. Pinealon is not an approved medicine; for memory complaints or cognitive decline, a medical assessment and established treatments come first.

Specifications

Origin / ManufacturerSynthetic
Active Components
Pinealon tripeptide (Glu-Asp-Arg)
StorageFollow the supplier's label; no validated stability data published
Form FactorCapsules or lyophilized powder (supplement and research-chemical market)

Frequently Asked Questions

Sources & References

Every clinical claim on this page traces to a primary peer-reviewed source.

  1. 1Khavinson V, Ribakova Y, Kulebiakin K, et al.. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation research. 2011;14(5):535-41. doi:10.1089/rej.2011.1172 PMID:21978084
  2. 2Fedoreyeva LI, Kireev II, Khavinson VKh, et al.. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. Biochemistry. Biokhimiia. 2011;76(11):1210-9. doi:10.1134/S0006297911110022 PMID:22117547
  3. 3Arutjunyan A, Kozina L, Stvolinskiy S, et al.. Pinealon protects the rat offspring from prenatal hyperhomocysteinemia. International journal of clinical and experimental medicine. 2012;5(2):179-85. PMID:22567179
  4. 4Mendzheritsky AM, Karantysh GV, Ryzhak GA, et al.. Pinealon and Cortexin influence on behavior and neurochemical processes in 18-month aged rats within hypoxia and hypothermia. Advances in gerontology = Uspekhi gerontologii. 2015;28(3):532-539. PMID:28509493
  5. 5Khavinson V, Ilina A, Kraskovskaya N, et al.. Neuroprotective Effects of Tripeptides-Epigenetic Regulators in Mouse Model of Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland). 2021;14(6). doi:10.3390/ph14060515 PMID:34071923
  6. 6Khavinson V, Linkova N, Kozhevnikova E, et al.. EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease. Molecules (Basel, Switzerland). 2020;26(1). doi:10.3390/molecules26010159 PMID:33396470
  7. 7Khavinson VK, Linkova NS, Rudskoy AI, et al.. Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters. Biomolecules. 2023;13(3). doi:10.3390/biom13030552 PMID:36979488
  8. 8Meshchaninov VN, Tkachenko EL, Zharkov SV, et al.. EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION. Advances in gerontology = Uspekhi gerontologii. 2015;28(1):62-7. PMID:26390612
  9. 9Bashkireva AS, Artamonova VG. The peptide correction of neurotic disorders among professional truck-drivers. Advances in gerontology = Uspekhi gerontologii. 2012;25(4):718-28. PMID:23734521

Related Peptides

Search

Search across products, blog posts, wiki articles, and more.